Detalhe da pesquisa
1.
Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial.
Blood
; 140(9): 980-991, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35687757
2.
Sutimlimab provides clinically meaningful improvements in patient-reported outcomes in patients with cold agglutinin disease: Results from the randomised, placebo-controlled, Phase 3 CADENZA study.
Eur J Haematol
; 110(3): 280-288, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36403132
3.
Sustained inhibition of complement C1s with sutimlimab over 2 years in patients with cold agglutinin disease.
Am J Hematol
; 98(8): 1246-1253, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37246953
4.
Sutimlimab improves quality of life in patients with cold agglutinin disease: results of patient-reported outcomes from the CARDINAL study.
Ann Hematol
; 101(10): 2169-2177, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35999387
5.
Characterization of breakthrough hemolysis events observed in the phase 3 randomized studies of ravulizumab versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria.
Haematologica
; 106(1): 230-237, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31949012
6.
A Retrospective Study of the Combination of Rituximab, Cyclophosphamide and Dexamethasone for the Treatment of Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia.
Acta Haematol
; 143(3): 244-249, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31665725
7.
Correction to: Sutimlimab improves quality of life in patients with cold agglutinin disease: results of patientreported outcomes from the CARDINAL study.
Ann Hematol
; 103(5): 1803, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38519606
8.
Ethnic and racial difference in Helicobacter pylori infection in patients with immune thrombocytopenia treated at a major urban medical center.
Platelets
; 30(3): 413-417, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-29580123
9.
Eculizumab in Pregnant Patients with Paroxysmal Nocturnal Hemoglobinuria.
N Engl J Med
; 373(11): 1032-9, 2015 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26352814
10.
Complement C1s inhibition with sutimlimab results in durable response in cold agglutinin disease: CARDINAL study 1-year interim follow-up results.
Haematologica
; 107(7): 1698-1702, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35172561
11.
Life-threatening delayed hyperhemolytic transfusion reaction in a patient with sickle cell disease: effective treatment with eculizumab followed by rituximab.
Transfusion
; 55(10): 2398-403, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25989361
12.
Effective treatment of chemotherapy induced atypical Haemolytic Uraemic Syndrome: a case series of 7 treated patients.
Br J Haematol
; 183(1): 136-139, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28857126
13.
Biomarkers and laboratory assessments for monitoring the treatment of patients with paroxysmal nocturnal hemoglobinuria: Differences between terminal and proximal complement inhibition.
Blood Rev
; 59: 101041, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36732204
14.
Long-term sutimlimab improves quality of life for patients with cold agglutinin disease: CARDINAL 2-year follow-up.
Blood Adv
; 7(19): 5890-5897, 2023 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37459203
15.
Pegcetacoplan versus eculizumab in patients with paroxysmal nocturnal haemoglobinuria (PEGASUS): 48-week follow-up of a randomised, open-label, phase 3, active-comparator, controlled trial.
Lancet Haematol
; 9(9): e648-e659, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36055332
16.
Thrombosis in patients with paroxysmal nocturnal hemoglobinuria.
Semin Thromb Hemost
; 37(3): 315-21, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21455865
17.
Acute ST-Segment Elevation Myocardial Infarction as Initial Presentation of Atypical Hemolytic-Uremic Syndrome.
JACC Case Rep
; 3(4): 561-565, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34317581
18.
Cost burden of breakthrough hemolysis in patients with paroxysmal nocturnal hemoglobinuria receiving ravulizumab versus eculizumab.
Hematology
; 25(1): 327-334, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32856539
19.
Multidrug Therapy for Refractory Immune Thrombocytopenia in Pregnancy.
Obstet Gynecol
; 135(3): 723-727, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32028499
20.
Atypical hemolytic uremic syndrome: the role of complement pathway gene mutation analysis.
Clin Adv Hematol Oncol
; 12(4): 266-8, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25003358